BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 23033287)

  • 1. Research on and clinical importance of duplications in various chromosomal regions in addition to Philadelphia chromosome in chronic myeloid leukemia.
    Sever T; Kilicarslan C; Pehlivan M; Kaynar L; Yilmaz M; Eser B; Okan V; Kurnaz F; Cetin M; Pehlivan S
    J BUON; 2012; 17(3):490-6. PubMed ID: 23033287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
    Steinberg M
    Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of Philadelphia chromosome in patients with chronic myeloid leukemia from the Presov region in Slovakia (1995-2004).
    Boronova I; Bernasovsky I; Bernasovska J; Sotak M; Petrejcikova E; Bozikova A; Seliga P
    Bratisl Lek Listy; 2007; 108(10-11):433-6. PubMed ID: 18306721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia.
    Onida F; Ball G; Kantarjian HM; Smith TL; Glassman A; Albitar M; Scappini B; Rios MB; Keating MJ; Beran M
    Cancer; 2002 Oct; 95(8):1673-84. PubMed ID: 12365015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complex variant Philadelphia translocations involving the short arm of chromosome 6 in chronic myeloid leukemia.
    La Starza R; Testoni N; Lafage-Pochitaloff M; Ruggeri D; Ottaviani E; Perla G; Martelli MF; Marynen P; Mecucci C
    Haematologica; 2002 Feb; 87(2):143-7. PubMed ID: 11836164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel complex t(V;9;22) rearrangements in three cases with chronic myeloid leukemia and a rare translocation in a case with classical Philadelphia chromosome.
    Mkrtchyan H; Ghazaryan S; Avetisyan G; Hovhannisyan A; Muradyan L; Daghbashyan S; Karst C; Gross M; Hinreiner S; Aroutiounian R; Liehr T
    Oncol Rep; 2008 Jul; 20(1):99-104. PubMed ID: 18575724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
    Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
    Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A complex translocation t(5;9;22) in Philadelphia cells involving the short arm of chromosome 5 in a case of chronic myelogenous leukemia.
    Al-Achkar W; Wafa A; Nweder MS
    J Exp Clin Cancer Res; 2007 Sep; 26(3):411-5. PubMed ID: 17987804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the impact of imatinib mesylate therapy on the prognosis of patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-alpha regimens for early chronic phase.
    Kantarjian H; O'Brien S; Cortes J; Shan J; Giles F; Garcia-Manero G; Verstovsek S; Faderl S; Rios MB; Talpaz M
    Cancer; 2003 Oct; 98(7):1430-7. PubMed ID: 14508830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis and identification of variant Ph chromosome translocation in patients with chronic myelogenous leukemia by conventional cytogenetics and fluorescence in situ hybridization].
    Liu XP; Liu SH; Li CW; Bo LJ; Qin S; Dai Y; Qian LS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Jun; 12(3):298-303. PubMed ID: 15228654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cytogenetics of chronic myeloid leukemia with atypical t(6;9) (p23;q34) translocation.
    Jadayel D; Calabrese G; Min T; van Rhee F; Swansbury GJ; Dyer MJ; Maitland J; Palka G; Catovsky D
    Leukemia; 1995 Jun; 9(6):981-7. PubMed ID: 7596189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of BCR/ABL gene mutation in CML is time dependent and dependent on the pressure exerted by tyrosine kinase inhibitor.
    Vaidya S; Vundinti BR; Shanmukhaiah C; Chakrabarti P; Ghosh K
    PLoS One; 2015; 10(1):e0114828. PubMed ID: 25629972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complex chromosome rearrangements may locate the bcr/abl fusion gene sites other than 22q11.
    Sessarego M; Fugazza G; Bruzzone R; Ballestrero A; Miglino M; Bacigalupo A
    Haematologica; 2000 Jan; 85(1):35-9. PubMed ID: 10629589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytogenetic and molecular studies in patients with chronic myelogenous leukemia without Ph chromosome and with unusual Ph translocation].
    Xue YQ
    Zhonghua Yi Xue Za Zhi; 1993 Apr; 73(4):209-12, 252-3. PubMed ID: 8395313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal evolution with double Ph followed by tetraploidy in imatinib-treated chronic myeloid leukemia with e19a2 transcript in transformation.
    Oshikawa G; Kurosu T; Arai A; Murakami N; Miura O
    Cancer Genet Cytogenet; 2010 May; 199(1):56-61. PubMed ID: 20417871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute lymphoblastic leukemia without the Philadelphia chromosome occurring in chronic myelogenous leukemia with the Philadelphia chromosome.
    Jin Huh H; Won Huh J; Myong Seong C; Lee M; Soon Chung W
    Am J Hematol; 2003 Nov; 74(3):218-20. PubMed ID: 14587058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High incidence of large deletions in the PMS2 gene in Spanish Lynch syndrome families.
    Brea-Fernández AJ; Cameselle-Teijeiro JM; Alenda C; Fernández-Rozadilla C; Cubiella J; Clofent J; Reñé JM; Anido U; Milá M; Balaguer F; Castells A; Castellvi-Bel S; Jover R; Carracedo A; Ruiz-Ponte C
    Clin Genet; 2014 Jun; 85(6):583-8. PubMed ID: 23837913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clonal evolution of abnormal Philadelphia chromosome-negative cells after imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia].
    Jiang Q; Chen SS; Jiang B; Jiang H; Lu Y; Qiu JY; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):23-6. PubMed ID: 15946504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
    Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
    Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examination of chromosome 7p22 candidate genes RBaK, PMS2 and GNA12 in familial hyperaldosteronism type II.
    Jeske YW; So A; Kelemen L; Sukor N; Willys C; Bulmer B; Gordon RD; Duffy D; Stowasser M
    Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):380-5. PubMed ID: 18307725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.